接受肾脏替代治疗的危重患者60天病死率预测:预测模型的外部验证
本研究使用MIMIC-III数据库中1053例需要肾脏替代治疗(RRT)的危重患者,对近期开发的ATN 60天病死率预测模型进行外部验证。在包含入ICU时血清肌酐正常或异常患者的混合人群中,非整数化风险模型的区分度中等,c-statistic为0.71;在基线sCr异常的患者中,整数风险模型区分度较好,c-statistic为0.76(95%CI 0.71-0.81)。校准方面,H-L检验仅在入ICU时sCr正常/轻度异常患者中良好,但GiViTi校准带显示无论入ICU时sCr如何,所有模型均未显著偏离平分线。再拟合模型的c-statistic为0.85,与推导队列相似。作者认为该模型可用于广谱危重患者,但需在临床实施前持续进行外部验证和更新。
要点
- 在1053例需RRT的危重患者中,非整数化ATN模型在混合人群的区分度中等,c-statistic为0.71。
- 基线sCr异常患者中,整数风险模型区分度较好,c-statistic为0.76(95%CI 0.71-0.81)。
- H-L检验仅在入ICU时sCr正常/轻度异常患者中良好;校准带显示所有模型均未显著偏离平分线。
- 再拟合模型c-statistic为0.85,与推导队列相似,提示模型随时间更新可改善区分度。
- 作者认为ATN预后模型可用于广谱危重RRT患者,但临床实施前需持续外部验证和更新。
适用人群与场景
- MIMIC-III数据库中1053例需要肾脏替代治疗(RRT)的危重患者。
- 包括入ICU时血清肌酐正常或异常的患者;基线sCr异常者单独分析。
研究设计与关键结果
- 研究类型:预测模型外部验证;数据来源:MIMIC-III数据库;样本量:1053例需RRT的危重患者。
- 混合人群(入ICU时sCr正常或异常):非整数化风险模型区分度中等,c-statistic为0.71。
- 基线sCr异常患者:整数风险模型区分度较好,c-statistic为0.76(95%CI 0.71-0.81)。
- 校准:H-L检验仅在入ICU时sCr正常/轻度异常患者中良好;GiViTi校准带显示无论入ICU时sCr如何,所有模型均未显著偏离平分线。
- 再拟合模型c-statistic为0.85,与推导队列相似。
证据类型、等级与局限
- 证据类型:预测模型外部验证研究(基于MIMIC-III数据库的队列分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ATN预后模型可用于广谱危重RRT患者,但临床实施前需持续进行外部验证和更新。
- 原文指出在包含入ICU时sCr升高患者的队列中模型仅显示中等区分度,再拟合模型可改善区分度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: A recent prognostic model, predicting 60-day case fatality in critically ill patients requiring renal replacement therapy (RRT), has been developed (Acute Renal Failure Trial Network [ATN] study). Because many prognostic models are suggested in literature, but just a few have found its way into clinical practice, we aimed to externally validate this prediction model in an independent cohort.
METHODS: A total of 1,053 critically ill patients requiring RRT from the MIMIC-III database were analyzed. The models' discrimination was evaluated using c-statistics. Calibration was evaluated by Hosmer-Lemeshow (H-L) test and GiViTi calibration belt.
RESULTS: In a case-mix population, including patients with normal or altered serum creatinine (sCr) at intensive care unit admission, discrimination was moderate, with a c-statistic of 0.71 in the nonintegerized risk model. In patients with altered baseline sCr, better discrimination was achieved with the integer risk model (0.76, 95% confidence interval, 0.71-0.81). As for the calibration, although the H-L test was good only in patients with normal/slightly altered sCr at admission, the calibration belt disclosed no significant deviations from the bisector line for any of the models in patients, regardless of admission sCr. Of note, a refitted model had a c-statistics of 0.85, similar to the derivation cohort.
CONCLUSIONS: The ATN prognostic model can be useful in a broad cohort of critically ill patients. Although it showed only moderate discrimination capacity when patients with elevated admission sCr were included, using a refitted model improved it, illustrating the need for continuous external validation and updating of prognostic models over time before their implementation in clinical practice.
参考来源
- Carvalho GMC, Leite TT, Libório AB, et al. Prediction of 60-Day Case Fatality in Critically Ill Patients Receiving Renal Replacement Therapy: External Validation of a Prediction Model. Shock. 2018. PMID: 29112632. doi:10.1097/SHK.0000000000001054
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。